Lipoprotein Lipase Antikörper
-
- Target Alle Lipoprotein Lipase (LPL) Antikörper anzeigen
- Lipoprotein Lipase (LPL)
-
Reaktivität
- Human, Rind (Kuh)
- Wirt
- Bitte anfragen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Lipoprotein Lipase Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- Human LPL whole protein. Recognizes specifically LPL from human and bovine.
- Isotyp
- IgG1
- Top Product
- Discover our top product LPL Primärantikörper
-
-
- Applikationshinweise
- Western blot (1:1000) and ELISA (1:2000~5000) in lipid metabolic research.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1mg/ml
- Buffer
- PBS, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- Lipoprotein Lipase (LPL)
- Andere Bezeichnung
- LPL (LPL Produkte)
- Synonyme
- HDLCQ11 antikoerper, LIPD antikoerper, fb62e04 antikoerper, fc49b03 antikoerper, wu:fb62e04 antikoerper, wu:fc49b03 antikoerper, LPL antikoerper, lipd antikoerper, hdlcq11 antikoerper, lpl antikoerper, LOC100223817 antikoerper, lipoprotein lipase antikoerper, LPL antikoerper, Lpl antikoerper, lpl antikoerper
- Hintergrund
- Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion. Recently, it has also been shown that LPL promote the development of atherosclerosis through facilitation of monocyte adhesion to endothelial cells, stimulation of tumor necrosis factor alpha (TNF ) secretion and induction of vascular smooth muscle cell proliferation.
- Gen-ID
- 4023
- Pathways
- Lipid Metabolism
-